Atlas Trials

Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients

Clinical trial NCT05733026 · UNKNOWN

Trial details

NCT number
NCT05733026
Sponsor
Ain Shams University
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast Cancer
Start date
2020-08-01
Primary completion
2023-01-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.